
Adeno-associated virus (AAV)-based gene therapies enable targeted delivery of genetic payloads are difficult to characterize due to limited supplies. As a result, critical quality attributes like subvisible particles—key to safety, efficacy, and regulatory approval—often get overlooked until it’s too late. This application note demonstrates how complete morphological analysis combined with fluorescence membrane microscopy (FMM) provides deep insight into serotype-specific aggregate formation and stability—using as little as 10 µL per sample.
Unlike differential scanning fluorimetry (DSF), which failed to predict aggregation trends, this approach accurately quantifies subvisible particles and membrane coverage under thermal, rotational, and freeze-thaw stress. By distinguishing proteinaceous aggregates, FMM offers a more reliable method for assessing AAV product quality and formulation stability, helping teams make better decisions on shelf life and efficacy throughout development.

Copyright © 2026 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy